News Releases

Rahway, N.J. – Sept. 13, 2025 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced new data demonstrating the safety and efficacy of NUMELVI® (atinvicitinib) Tablets for Dogs and MOMETAMAX ULTRA® (gentamicin, posaconazole, and mometasone furoate otic suspension) for dogs. These data were presented at the 35th […]

Read more

NUMELVI, a highly-selective, second-generation JAK inhibitor for dogs, delivers at least 10-fold greater selectivity for JAK1 compared with JAK2, JAK3, and tyrosine kinase (TYK)–2, and is suitable for dogs as young as 6 months. RAHWAY, N.J., July 24, 2025 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today […]

Read more

NUMELVI from MSD Animal Health is the First and Only Second-Generation Janus Kinase (JAK) Inhibitor for the Treatment of Pruritus Associated with Allergic Dermatitis Including Atopic Dermatitis and Treatment of Clinical Manifestations of Atopic Dermatitis in Dogs RAHWAY, N.J., July 24, 2025 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., […]

Read more

Rahway, NJ., June 12, 2025 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced that the European Medicines Agency’s Committee for Veterinary Medicinal Products (CVMP) issued a positive opinion for the NOBIVAC® L6 and NOBIVAC® LoVo L6 vaccines. If the European Commission (EC) adopts the recommendation, the […]

Read more

The new formulation targets internal and external parasites, expanding the BRAVECTO® portfolio Rahway, NJ, – November 26, 2024 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced that the European Commission has granted the marketing authorization for BRAVECTO® TriUNO, a new formulation of BRAVECTO (fluralaner) for dogs that targets […]

Read more

Vaccine can now be administered intramuscularly or through subcutaneous injection as well as at the same time as BOVILIS® CRYPTIUM® Subcutaneous injections are generally well-tolerated by animals, can minimize pain and distress, and improve meat quality[i] Rahway, N.J., October 15, 2024 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA […]

Read more

RAHWAY, N.J., March 14, 2024 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced that the European Medicines Agency’s Committee for Veterinary Medicinal Products (CVMP) issued a positive opinion for the NOBILIS MULTRIVA™ RT+IBm+ND+Gm+REOm+EDS vaccine to be administered intramuscularly in chickens from eight weeks of age, to […]

Read more